A Clinical Trial of Elsunersen in Pediatric SCN2A-DEE to Assess Efficacy and Safety

Recruiting now · Phase 3

Conditions studied: Epileptic Encephalopathy, SCN2A Encephalopathy

In brief

A Multi-Center, Single-Arm Clinical Trial to Investigate the Efficacy and Safety of Elsunersen in Pediatric Participants with Early Onset SCN2A Developmental and Epileptic Encephalopathy

Key facts

Study ID
NCT07019922
Run by
Praxis Precision Medicines
People needed
40
Starts
2025-08-13
Expected to finish
2028-12-01
Last updated by the study team
2026-08-03

Who can join

Age: 0 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.